A Study Evaluating the Efficacy and Safety of Baricitinib in Systemic Sclerosis

NCT05300932 · clinicaltrials.gov ↗
PHASE4
Phase
ACTIVE_NOT_RECRUITING
Status
60
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Tongji Hospital

Collaborators